Navigation Links
Transgenomic, Inc. Acquires Exclusive Worldwide License to Predictive Markers for Cancer Drug Response
Date:5/26/2011

OMAHA, Neb., May 26, 2011 /PRNewswire/ -- Transgenomic, Inc. (OTC/BB: TBIO) announced today that it has acquired an exclusive worldwide license to Montefiore Medical Center's (Bronx, NY, US) patent application, "Method of Determining the Sensitivity of Cancer Cells to EGFR Inhibitors including cetuximab, panitumumab and erlotinib".  The invention relates to the discovery by Montefiore scientists and collaborators that tumor-specific mutations in the genes PIK3CA and PTEN can aid in predicting patient non-response to epidermal growth factor receptor (EGFR) inhibitors, a widely prescribed class of cancer drugs.

Transgenomic is incorporating the PIK3CA and PTEN gene assays into its rapidly expanding menu of cancer profiling tests available through its clinical reference laboratories and is developing testing kits for sale to other labs. Testing of these genes is also being offered to support drug development research by pharmaceutical companies that have been expressing great interest in these genes and in Transgenomic's proprietary, ultra-sensitive mutation-detection technologies. At the American Association for Cancer Research meeting in April of this year, Transgenomic described methods for detecting tumor-specific mutations at such low levels that it may be possible to identify them in patients' blood samples, not just in surgically obtained tumor tissues.

"This exclusive license from Montefiore strengthens our cancer-related diagnostic test portfolio and is integral to the continued development of our leadership position in oncology," said Craig Tuttle, CEO of Transgenomic. "At Transgenomic, we are uniquely equipped to maximize the value of these genetic discoveries by combining them with the unparalleled sensitivity of our proprietary mutation-detection technologies. Our exclusive access to this new intellectual property will enable us to provide the most comprehensive analysis for predicting response to ca
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
2. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
3. Transgenomic, Inc. Expands SURVEYOR® Scan Product Line With BRAF and PIK3CA Mutation Detection Kits
4. Transgenomic, Inc. Presents Its Latest Technology at the BIT Life Sciences World DNA and Genome Day Conference, Dalian, China
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
7. U.S. Preventive Medicine Acquires Specialty Disease Management
8. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
9. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
10. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
11. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Carolina , 31. Juli 2014 ... Miami bekanntgegeben, um die ... Zentral- und Lateinamerika zu erfüllen. Die neu ausgebaute ... biologische Proben und für die Zusammenlegung von Sendungen ... wird zusätzliche Lagerkapazität bereitstellen.   Logo ...
(Date:7/31/2014)... NOTTINGHAM, England , July 31, 2014 /PRNewswire/ ... ) today announced that its subsidiary, Molecular Profiles ... that will support pharmaceutical and biotech drug developers ... Profiles, pharmaceutical development services will be supported by ... (DMPK) to give clients a smarter route into ...
(Date:7/31/2014)... 31, 2014 Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced that the Company will ... its partner Asahi Kasei Pharma Corporation (Asahi Kasei). ... submission of a regulatory application to the Japanese ... ® (collagenase clostridium histolyticum) for the treatment ...
Breaking Medicine Technology:Marken erweitert regionales Logistikzentrum in Miami 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
(Date:7/31/2014)... Reserve University medical and nursing school researchers hope ... patients who participate in clinical trials, a critical ... preventions. , For various reasonsincluding a lack of ... of cancer patients take part in trials of ... cancer patients who are eligible still don,t enroll, ...
(Date:7/31/2014)... Thousands of independent community pharmacists, ... have come together today to kick off ThoughtSpot ... , "ThoughtSpot 2014 is Good Neighbor Pharmacy’s annual ... to help their businesses thrive," stated AJ Caffentzis, ... long-standing commitment to independent community pharmacies, and at ...
(Date:7/31/2014)... India (PRWEB) July 31, 2014 Web ... an ISO 9001:2008 certified internet marketing firm, has recently ... order to make this service affordable for everyone, the ... of the service. , Web Programming Services has ... the world of brochure designing and likely expectations of ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Recently, Agebc.com, a ... dresses, has revealed its new selection of trendy mother ... them are offered at promotional prices now, up to 68% ... line by adding the new range of mother of the ... to the international clients. So far, our online shop has ...
(Date:7/31/2014)... Calif., July 31, 2014 -- A new study by ... that a peptide called caerulein can convert existing cells ... 1 diabetes-insulin-producing beta cells. The study, published online July ... a new approach to treating the estimated 3 million ... living with type 1 diabetes. , "We have found ...
Breaking Medicine News(10 mins):Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:A new way to generate insulin-producing cells in Type 1 diabetes 2
... with four additional law suits, after the Liver Transplant Program ... ,Orange county Superior court has been a witness ... died just waiting for the transplants; the fourth, a patient ... program transparent to gross mismanagement has to also battle the ...
... are on tenterhooks, preventing the spread of the deadly virus H5N1, ... Eastern past of France. // The farm in Versailleux,on Thursday, that ... the lake where wild ducks were among the first to get ... ,This is perhaps the first time that a European Union farm ...
... prison in Guantanamo Bay to force feed the prisoners ... // through their noses has raised controversies among medical ... the fundamental principles of medical ethics. ,In ... targeted at extension of co-operation by the detainees. A ...
... mosquito-borne disease for which there is no known cure or ... of La Reunion Island // on Indian Ocean. As Nearly ... Xavier Bertrand, French Health Minister. ,More than 130, ... mortalities could be related directly or indirectly to the epidemic ...
... and unwholesomeness of visually appetizing foods, sugar coated cereals ... food strategies,// and yo-yo to consumer palettes, dictated by ... to keep heart disease and cancer at bay. ... a nutrition expert at the University of Maryland, ...
... offered insights into why Africans have an increased susceptibility ... compared to whites. // Worldwide, approximately more than ... 2 million people die due to the same every ... to official sources, the incidence of TB is eight ...
Cached Medicine News:Health News:Medical Ethics Violated By Prison Officials In Guantanamo Bay 2Health News:Wholly Ingrained: White or Brown? Food War Going Racist? Get to the Heart of the Matter 2Health News:Vitamin D May Help In Fight Against Tuberculosis 2
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...
... topics included: Ergogenic aids, anabolic steroids, ... swimming, skiing, tennis, common sports problems, ... cardiology for athletes, exercise, exercise (treadmill) ... injuries, heat-related illness, acclimatization, neuropraxia, overtraining ...
Pocket Sports Medicine is the result of a collaboration between outstanding Editors and Contributors. The program covers the field so that both specialists and general orthopedists will find expert g...
Medicine Products: